Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo therapy targets aggressive brain tumors

NCT ID NCT04699773

First seen May 14, 2026 · Last updated Jun 11, 2026 · Updated 7 times

Summary

This study tests a two-step treatment for people newly diagnosed with high-grade gliomas, a fast-growing type of brain tumor. First, a laser is used to heat and destroy tumor tissue. Then, a short course of radiation is given to kill remaining cancer cells. The goal is to safely control the tumor and delay its return. About 32 adults will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baltimore Washington Medical Center

    RECRUITING

    Glen Burnie, Maryland, 21061, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

  • Central Maryland Radiation Oncology

    RECRUITING

    Columbia, Maryland, 21044, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-••••

  • Maryland Proton Treatment Center

    RECRUITING

    Baltimore, Maryland, 21201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • UCH Kaufman Cancer Center

    RECRUITING

    Bel Air, Maryland, 21014, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-••••

  • University of Maryland Greenebaum Cancer Center

    RECRUITING

    Baltimore, Maryland, 21201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

brain cancer glioblastoma glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.